Last update:

Alzheimer's disease & dementia news

Alzheimer's disease & dementia

SARS-CoV-2 can cause buildup of Alzheimer's-related peptides in retina

A new Yale study has found a promising target for treating the brain fog that can follow COVID-19 and offers new insight into a hypothesis about the origin of Alzheimer's disease.

Medical research

Brain biomarkers of Alzheimer's disease can be detected as early as middle age

A Finnish population study shows that signs related to Alzheimer's disease may already be found in the brain in middle age. In the future, blood-based biomarkers associated with Alzheimer's disease could allow earlier detection ...

Alzheimer's disease & dementia

People diagnosed with dementia are living longer, global study shows

A person diagnosed with dementia has improved survival outcomes in recent years amid significant progress in dementia diagnosis and care, according to a recent multinational study led by a University of Waterloo researcher.

Psychology & Psychiatry

New study maps four key pathways to Alzheimer's disease

UCLA Health researchers have identified four distinct pathways that lead to Alzheimer's disease by analyzing electronic health records, offering new insights into how the condition develops over time rather than from isolated ...

Alzheimer's disease & dementia

Many dementia cases could be prevented, but far from all: Study

Millions of cases of dementia could be prevented or delayed by reducing a range of risk factors such as smoking or air pollution, according to a major new study, though outside experts warn that such measures can only go ...

Alzheimer's disease & dementia

Improving Alzheimer's disease imaging, with fluorescent sensors

Neurotransmitter levels in the brain can indicate brain health and neurodegenerative diseases like Alzheimer's. However, the protective blood-brain barrier (BBB) makes delivering fluorescent sensors that can detect these ...

Alzheimer's disease & dementia

Accuracy of diagnostic blood tests for Alzheimer's disease varies

Neurologists diagnose cognitive impairment with a clinical exam of memory and thinking skills. To determine whether Alzheimer's disease is the cause of the cognitive impairment, evidence of the specific brain changes that ...

Medications

European medicines watchdog rejects new Alzheimer's drug

Europe's medicines watchdog on Friday rejected a marketing request for a new Alzheimer's disease treatment, saying the risks of the medicine's side effects, including potential brain bleeding, outweighed the benefits.

Alzheimer's disease & dementia

New shingles vaccine could reduce risk of dementia

A study of more than 200,000 people by researchers at the University of Oxford found at least a 17% reduction in dementia diagnoses in the six years after the new recombinant shingles vaccination, equating to 164 or more ...